• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Mid-Morning Market Update: Markets Open Higher; Dow Gains 300 Points

    4/27/22 10:03:26 AM ET
    $AGRX
    $ENPH
    $JKS
    $MOLN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Semiconductors
    Technology
    Get the next $AGRX alert in real time by email

    U.S. stocks traded higher this morning, with the Dow Jones gaining more than 300 points on Wednesday.

    Following the market opening Wednesday, the Dow traded up 0.91% to 33,543.56 while the NASDAQ rose 1.55% to 12,683.73. The S&P also rose, gaining, 1.19% to 4,224.93.

    Also check this: Executives Buy Around $65M Of 3 Stocks


    Leading and Lagging Sectors


    Information technology shares rose by 2.9% on Wednesday. Meanwhile, top gainers in the sector included Enphase Energy, Inc. (NASDAQ:ENPH), up 15% and JinkoSolar Holding Co., Ltd. (NYSE:JKS) up 11%.


    In trading on Wednesday, communication services shares dipped by 1.3%.


    Top Headline


    Boeing Company reported wider-than-expected first quarter loss.

    Boeing’s adjusted core loss came in at $2.75 per share, versus analysts’ estimates of a $0.25 per share loss. Group revenues declined 8% from last year to $14 billion, versus analysts' expectations of $16.02 billion

     

    Equities Trading UP


    Nutex Health, Inc. (NASDAQ:NUTX) shares shot up 30% to $9.96 after jumping 74% on Tuesday.


    Shares of TradeUP Global Corporation (NASDAQ:TUGC) got a boost, shooting 17% to $10.78.


    Repligen Corporation (NASDAQ:RGEN) shares were also up, gaining 13% to $161.00 after reporting upbeat Q1 results.

     

    Equities Trading DOWN

    Molecular Partners AG (NASDAQ:MOLN) shares tumbled 38% to $8.62. The company’s collaborating partner Amgen for MP0310 (AMG 506) will return the global rights of MP0310 to Molecular Partners following a strategic pipeline review.


    Shares of Agile Therapeutics, Inc. (NASDAQ:AGRX) were down 26% to $3.31 following effectiveness of 1:40 reverse stock split.


    NCR Corporation (NYSE:NCR) was down, falling 21% to $29.44 after the company reported worse-than-expected Q1 EPS and sales results. The company also cut its FY22 EPS and sales guidance.

    Also check out: 2 Stocks Under $5 Insiders Are Aggressively Buying


    Commodities

    In commodity news, oil traded down 1.4% to $100.28, while gold traded down 0.9% to $1,886.50.


    Silver traded down 0.1% Wednesday to $23.525 while copper fell 0.2% to $4.4535.



    Euro zone


    European shares were higher today. The eurozone’s STOXX 600 gained 0.8%, London’s FTSE 100 gained 0.8%, while Spain’s IBEX 35 Index rose 0.6%. The German DAX gained 0.5%, French CAC 40 climbed 0.9% and Italy’s FTSE MIB Index gained 0.7%.

    The consumer confidence in France declined to 88 points in April from a revised reading of 90 points in March, while GfK Consumer Climate Indicator in Germany fell to -26.5 heading into May.


    Economics


    The goods trade deficit in the US rose to $125.3 billion in March from $106.3 billion in the previous month.


    U.S. wholesale inventories rose 2.3% month-over-month to $837.7 billion in March.


    The pending home sales index fell 1.2% for March.


    The Energy Information Administration’s weekly report on petroleum inventories in the U.S. is scheduled for release at 10:30 a.m. ET.


    The Treasury is set to auction 5-year notes at 1:00 p.m. ET.

    Check out this: 4 Stocks Under $2 Insiders Are Aggressively Buying

    COVID-19 Update

    The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 82,789,710 cases with around 1,019,000 deaths. India confirmed a total of at least 43,065,660 cases and 522,370 deaths, while Brazil reported over 30,378,060 COVID-19 cases with 662,940 deaths. In total, there were at least 510,925,220 cases of COVID-19 worldwide with more than 6,249,430 deaths.

    Get the next $AGRX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGRX
    $ENPH
    $JKS
    $MOLN

    CompanyDatePrice TargetRatingAnalyst
    Enphase Energy Inc.
    $ENPH
    2/4/2026$52.00Hold → Buy
    HSBC Securities
    Enphase Energy Inc.
    $ENPH
    2/4/2026$41.00Underperform → Market Perform
    BMO Capital Markets
    Enphase Energy Inc.
    $ENPH
    2/4/2026$54.00Sector Perform → Outperform
    RBC Capital Mkts
    Enphase Energy Inc.
    $ENPH
    2/4/2026$35.00 → $40.00Hold
    TD Cowen
    Molecular Partners AG
    $MOLN
    1/27/2026$13.00Buy
    H.C. Wainwright
    Enphase Energy Inc.
    $ENPH
    1/22/2026$37.00Sell → Neutral
    Citigroup
    Enphase Energy Inc.
    $ENPH
    1/20/2026$45.00Neutral → Buy
    Goldman
    Enphase Energy Inc.
    $ENPH
    1/13/2026Mkt Perform
    Raymond James
    More analyst ratings

    $AGRX
    $ENPH
    $JKS
    $MOLN
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Repligen Corporation

    SCHEDULE 13G/A - REPLIGEN CORP (0000730272) (Subject)

    2/17/26 10:26:21 AM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 10-K filed by Enphase Energy Inc.

    10-K - Enphase Energy, Inc. (0001463101) (Filer)

    2/13/26 9:38:22 PM ET
    $ENPH
    Semiconductors
    Technology

    SEC Form SCHEDULE 13G filed by Repligen Corporation

    SCHEDULE 13G - REPLIGEN CORP (0000730272) (Subject)

    2/5/26 1:36:41 PM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGRX
    $ENPH
    $JKS
    $MOLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Kothandaraman Badrinarayanan bought $259,884 worth of shares (5,000 units at $51.98) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/5/26 4:41:25 PM ET
    $ENPH
    Semiconductors
    Technology

    Chief Financial Officer Bates Jon Christian bought $102,532 worth of shares (750 units at $136.71), increasing direct ownership by 15% to 5,638 units (SEC Form 4)

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    11/28/25 2:11:24 PM ET
    $NUTX
    Real Estate

    President & CEO Kothandaraman Badrinarayanan bought $153,438 worth of shares (5,000 units at $30.69) (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    11/10/25 4:42:21 PM ET
    $ENPH
    Semiconductors
    Technology

    $AGRX
    $ENPH
    $JKS
    $MOLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nextpower Enters Multi-Year Gigawatt-Scale Steel Frame Supply Agreement with Jinko Solar (U.S.) Industries Inc. for Advanced Solar Modules

    Company Plans to Expand Steel Frames Manufacturing Capacity in the Southeast U.S. Nextpower™ (NASDAQ:NXT), a leading provider of intelligent power generation technology and solutions for solar power plants, today announced its second major commercial order for U.S.-manufactured steel module frames, entering into a multi-year supply agreement with Jinko Solar (U.S.) Industries Inc. (NYSE:JKS), one of the longest operating solar module manufacturers in the United States. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260217543196/en/ Under the agreement, Nextpower plans to supply more than one gigawatt (GW) of steel frames, scal

    2/17/26 9:05:00 AM ET
    $JKS
    $NXT
    Semiconductors
    Technology
    Industrial Machinery/Components
    Industrials

    Enphase Energy Introduces Power Control Software to Improve Commercial Solar Economics

    FREMONT, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company, announced that it has introduced Power Control software for IQ9™ and IQ8™ Microinverter-based small commercial solar systems. The solution is designed to help installers cut costs, simplify interconnection, and unlock projects that would otherwise stall due to unfavorable project economics. Enphase Power Control™ software simplifies interconnections, reduces permitting complexity, and avoids costly utility upgrades, making it easier and more cost-effective to design and install small commercial microinverter systems, especially in California. The new software requires

    2/17/26 8:00:00 AM ET
    $ENPH
    Semiconductors
    Technology

    Repligen to Report Fourth Quarter and Full Year 2025 Financial Results

    WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter 2025 financial results on Tuesday, February 24, 2026. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. ET to discuss business updates and financial results for the three- and twelve- month reporting periods ended December 31, 2025. The conference call will be accessible by dialing toll-free (800) 715-9871 for domestic callers and (646) 307-1963 for international callers. No passcode is required for the live call. In addition, a webcast will be accessible via the Investor Relations sec

    2/10/26 7:30:00 AM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGRX
    $ENPH
    $JKS
    $MOLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Enphase Energy upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded Enphase Energy from Hold to Buy and set a new price target of $52.00

    2/4/26 10:18:44 AM ET
    $ENPH
    Semiconductors
    Technology

    Enphase Energy upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Enphase Energy from Underperform to Market Perform and set a new price target of $41.00

    2/4/26 8:24:40 AM ET
    $ENPH
    Semiconductors
    Technology

    Enphase Energy upgraded by RBC Capital Mkts with a new price target

    RBC Capital Mkts upgraded Enphase Energy from Sector Perform to Outperform and set a new price target of $54.00

    2/4/26 8:24:40 AM ET
    $ENPH
    Semiconductors
    Technology

    $AGRX
    $ENPH
    $JKS
    $MOLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mora Richard sold $57,254 worth of shares (1,100 units at $52.05), decreasing direct ownership by 11% to 9,370 units (SEC Form 4)

    4 - Enphase Energy, Inc. (0001463101) (Issuer)

    2/12/26 7:15:04 PM ET
    $ENPH
    Semiconductors
    Technology

    SEC Form 4 filed by Director Saunders Scott J

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 1:04:42 PM ET
    $NUTX
    Real Estate

    SEC Form 4 filed by Director Reed Michael Lee

    4 - Nutex Health, Inc. (0001479681) (Issuer)

    2/9/26 1:01:09 PM ET
    $NUTX
    Real Estate

    $AGRX
    $ENPH
    $JKS
    $MOLN
    Leadership Updates

    Live Leadership Updates

    View All

    JinkoSolar Announces Results of 2025 Annual General Meeting

    SHANGRAO, China, Dec. 29, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. ("JinkoSolar" or the "Company") (NYSE:JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that all shareholders resolutions proposed at the Company's 2025 annual general meeting held today were duly passed. Specifically, the Company's shareholders passed the following ordinary resolutions approving: The re-election of Mr. Haiyun Cao as a director of the Company;The re-election of Mr. Wing Keong Siew as an independent director of the Company;The ratification of the appointment of PricewaterhouseCoopers Zhong Tian LLP as auditors of the Company for the fiscal year of 2

    12/29/25 12:13:00 AM ET
    $JKS
    Semiconductors
    Technology

    JinkoSolar Schedules 2025 Annual General Meeting to be Held on December 29, 2025

    SHANGRAO, China, Nov. 17, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. (the "Company," or "JinkoSolar") (NYSE:JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that it will hold its 2025 annual general meeting on Monday, December 29, 2025 at 10:00 a.m. (Beijing time) at 10F, No.1, Lane 1466, Shenchang Road, Minhang District, Shanghai, China, for the following purposes: To re-elect Mr. Haiyun Cao as a director of the Company;To re-elect Mr. Wing Keong Siew as an independent director of the Company;To ratify the appointment of PricewaterhouseCoopers Zhong Tian LLP as auditors of the Company for the fiscal year of 2025;To authorize the d

    11/17/25 12:01:00 AM ET
    $JKS
    Semiconductors
    Technology

    Enphase Energy Announces Partnership with Green Mountain Power to Launch Innovations in Vermont including the Home Battery Lease Program

    FREMONT, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced a new partnership with Green Mountain Power (GMP) in Vermont to launch innovations benefitting customers through technology and grid transformation. GMP selected Enphase to join its groundbreaking home battery lease program where customers have back up power when they need it and share stored energy during peak usage times so GMP can reduce costs for everyone. "We're thrilled to partner with Enphase to bring cutting-edge technology directly to our customers – strengthenin

    11/12/25 8:00:00 AM ET
    $ENPH
    Semiconductors
    Technology

    $AGRX
    $ENPH
    $JKS
    $MOLN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Repligen Corporation

    SC 13G/A - REPLIGEN CORP (0000730272) (Subject)

    11/14/24 1:22:37 PM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Nutex Health Inc.

    SC 13G - Nutex Health, Inc. (0001479681) (Subject)

    11/14/24 11:02:17 AM ET
    $NUTX
    Real Estate

    Amendment: SEC Form SC 13D/A filed by Molecular Partners AG

    SC 13D/A - MOLECULAR PARTNERS AG (0001745114) (Subject)

    10/29/24 4:32:33 PM ET
    $MOLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AGRX
    $ENPH
    $JKS
    $MOLN
    Financials

    Live finance-specific insights

    View All

    Repligen to Report Fourth Quarter and Full Year 2025 Financial Results

    WALTHAM, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter 2025 financial results on Tuesday, February 24, 2026. The Company will issue a press release before the market opens and will host a conference call at 8:30 a.m. ET to discuss business updates and financial results for the three- and twelve- month reporting periods ended December 31, 2025. The conference call will be accessible by dialing toll-free (800) 715-9871 for domestic callers and (646) 307-1963 for international callers. No passcode is required for the live call. In addition, a webcast will be accessible via the Investor Relations sec

    2/10/26 7:30:00 AM ET
    $RGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Enphase Energy Reports Financial Results for the Fourth Quarter of 2025

    FREMONT, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ:ENPH), a global energy technology company, announced today financial results for the fourth quarter of 2025, which included the summary below from its President and CEO, Badri Kothandaraman. We reported quarterly revenue of $343.3 million in the fourth quarter of 2025, along with 46.1% for non-GAAP gross margin. We shipped approximately 1.55 million microinverters, or 682.6 megawatts DC, and 150.1 megawatt hours (MWh) of IQ® Batteries. Highlights for the fourth quarter of 2025 are listed below: Revenue of $343.3 millionGAAP gross margin of 44.3% and non-GAAP gross margin of 46.1%, including 5.1% of tariff im

    2/3/26 4:05:00 PM ET
    $ENPH
    Semiconductors
    Technology

    Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026

    Specific tumor accumulation and attractive biodistribution highly supportive of MP0712 clinical development for treatment of DLL3-expressing cancersDosimetry data highlight Radio-DARPins as vector for precise delivery of potent alpha-emitting isotopes to tumorsMP0712 Phase 1/2a study open in U.S. with initial clinical data expected in 2026Molecular Partners to host conference call February 2 at 8AM ET (2PM CET), joined by renowned nuclear medicine expert Prof. Ken Herrmann, M.D. ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR Molecular Partners AG ((SIX: MOLN, NASDAQ:MOLN), a clinical-stage biotech company deve

    2/2/26 1:00:00 AM ET
    $MOLN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care